4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3-ethylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3-ethylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3-ethylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
Compound ID: | L310-2894 |
Compound Name: | 4-[(5-cyclopropyl-1,2,4-oxadiazol-3-yl)methyl]-N-(3-ethylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
Molecular Weight: | 468.53 |
Molecular Formula: | C23 H24 N4 O5 S |
Smiles: | CCc1cccc(c1)NS(c1cc2c(cc1C)N(Cc1nc(C3CC3)on1)C(CO2)=O)(=O)=O |
Stereo: | ACHIRAL |
logP: | 4.0934 |
logD: | 4.0911 |
logSw: | -4.1564 |
Hydrogen bond acceptors count: | 10 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 97.909 |
InChI Key: | GBBXWAMMASHEMT-UHFFFAOYSA-N |